Marc Benioff - Oct 22, 2021 Form 4 Insider Report for SALESFORCE.COM, INC. (CRM)

Signature
/s/ Anisha Mehta, Attorney-in-Fact for Marc Benioff
Stock symbol
CRM
Transactions as of
Oct 22, 2021
Transactions value $
-$4,637,410
Form type
4
Date filed
10/25/2021, 06:51 PM
Previous filing
Oct 22, 2021
Next filing
Oct 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $1.19M +20K +0.07% $59.34 29M Oct 22, 2021 Direct F1, F2
transaction CRM Common Stock Sale -$559K -1.94K -0.01% $288.96 29M Oct 22, 2021 Direct F1, F2, F3
transaction CRM Common Stock Sale -$953K -3.29K -0.01% $289.88 29M Oct 22, 2021 Direct F1, F2, F4
transaction CRM Common Stock Sale -$1.28M -4.4K -0.02% $291.17 29M Oct 22, 2021 Direct F1, F2, F5
transaction CRM Common Stock Sale -$2.41M -8.25K -0.03% $291.93 29M Oct 22, 2021 Direct F1, F2, F6
transaction CRM Common Stock Sale -$622K -2.13K -0.01% $292.59 29M Oct 22, 2021 Direct F1, F2, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -20K -13.67% $0.00 126K Oct 22, 2021 Common Stock 20K $59.34 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
F2 Other than the shares subject to the transactions reported in this Form 4 (which are held in the reporting person's name), shares are held in the Marc R. Benioff Revocable Trust.
F3 Weighted average price. These shares were sold in multiple transactions at prices ranging from $288.4400 to $289.4000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Weighted average price. These shares were sold in multiple transactions at prices ranging from $289.4800 to $290.4700 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 Weighted average price. These shares were sold in multiple transactions at prices ranging from $290.5300 to $291.5200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 Weighted average price. These shares were sold in multiple transactions at prices ranging from $291.5300 to $292.5100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 Weighted average price. These shares were sold in multiple transactions at prices ranging from $292.5300 to $292.8100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F8 Option vests over four years at the rate of 25% on November 25, 2015, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.